Overview
Cancer molecular testing and AI precision diagnosis and treatment tools.
Funding
USD estimates from the source recordListed 1 funding record. Latest funding: $5.1M (种子轮), Feb 28, 2025.
Annual trendUnit: USD estimate
| Date | Amount | Investors | Source |
|---|---|---|---|
| Feb 28, 2025 | $5.1M | PacBridge Capital Partners |
Valuation
USD estimates from the source recordListed 1 valuation record.
Annual trendUnit: USD estimate
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Source |
|---|---|---|---|
| Feb 28, 2025 | — | PacBridge Capital Partners |
Revenue
USD estimates from the source recordNo revenue records are listed yet.
Annual trendUnit: USD estimate
No chartable revenue estimates yet.
No revenue rows to list.
Team, products & investors
Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
癌症分子检测与 AI 精准诊疗工具